| For: | Sharma T, Kaushal N, Garla R. Toxins to treatments: Impact of environmental pollutants, gut microbiota, and natural compounds on non-alcoholic fatty liver disease progression. World J Hepatol 2025; 17(8): 108772 [PMID: 40901604 DOI: 10.4254/wjh.v17.i8.108772] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v17/i8/108772.htm |
| Number | Citing Articles |
| 1 |
Bandy Chen, Laurent Gautron. Gut-derived lipopolysaccharides and metabolic endotoxemia: a critical review. American Journal of Physiology-Endocrinology and Metabolism 2025; 329(5) doi: 10.1152/ajpendo.00355.2025
|
| 2 |
Eslam Abady, Hazem AbuEl-Enien, Panos I. Tamvakologos, Karrar Naem Karam, Noor ul Ain Saleem, Abdul Haseeb Hasan, Staisy Mariyam Soju, Syeda Maham Guftar Shah, Maryam Nasir, Yahya Samadi, Zarqa Yasin. Ferroptosis may link gut microbiota dysbiosis to the progression of metabolic dysfunction associated steatotic liver disease. Discover Medicine 2026; 3(1) doi: 10.1007/s44337-026-00682-w
|
| 3 |
Ning Wang, Xiao-peng Zhang, Jing Leng, Xiu-li Chang, Jing Xu, Hui-min Zhang, Ke-lei Qian, Ping Xiao, Xu-dong Jia, Xin-yu Hong. METTL16-mediated m6A modification regulates SENP3-LTF axis and ferroptosis in Nd(NO₃)₃-induced hepatotoxicity. Ecotoxicology and Environmental Safety 2026; 325 doi: 10.1016/j.ecoenv.2026.120899
|
| 4 |
Felix Wambua Muema, Catherine M. Miller, Lionel Hebbard, Phurpa Wangchuk, Asmat Ullah. Current Therapeutic Strategies, Recent Advances and the Emerging Potential of Natural Products in Hepatocellular Carcinoma. Scientifica 2026; 2026(1) doi: 10.1155/sci5/3431270
|
| 5 |
Qin Wen, Xingmei Yin, Chenyang Liu, Chaofan Li, Xingxing Yuan. Environmental Hepatotoxicity: A Continuous Pathological Progression Model, Mechanisms, and Stage‐Oriented Intervention Strategies. Journal of Applied Toxicology 2026; doi: 10.1002/jat.70347
|